Users researching soft-tissue injury protocols, post-surgical recovery, or chronic tendinopathy.
BPC-157 drives local tissue repair (angiogenesis, gut healing) with a short half-life requiring daily dosing. TB-500 drives systemic cell migration with a ~2-day half-life requiring only 2× weekly. Community users stack them ("Wolverine Stack") because the mechanisms are complementary — BPC-157 for local injury sites, TB-500 for the broader cellular migration signal.
Log doses, upload labs, watch the biomarkers trend. StackAI reads your panel in context of what you're actually running.
Start tracking free →Informational comparison only — not medical advice. Research-stage compounds discussed are not FDA-approved unless specifically noted. Any protocol decision should be made with a licensed healthcare provider.